secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001493152-25-001870
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma files corporate presentation; no material financial or operational details disclosed
--------------------------------------------------------------------------------

- Filing under Item 7.01 for an investor presentation dated January 13, 2025.
- No earnings, clinical data, guidance changes, or other material facts included in the filing or exhibit.
- Exhibit 99.1 attached but contains no extractable substantive content in the provided text.
- Presentation was made to investment community; specific slide content not available for summary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225001870/0001493152-25-001870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315225001870/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer